← Back to Search

Procedure

Experimental study arm for Pulmonary Hypertension (PHINDER Trial)

N/A
Recruiting
Research Sponsored by United Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 3 weeks.
Awards & highlights

PHINDER Trial Summary

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).

Eligible Conditions
  • Pulmonary Hypertension
  • Interstitial Lung Disease

PHINDER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 3 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 3 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients with PH as indicated by RHC
Secondary outcome measures
Percentage of patients with severe PH as indicated by RHC

PHINDER Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental study armExperimental Treatment1 Intervention
All enrolled patients in this single arm study will receive a RHC.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Right heart catheterization (RHC)
2012
N/A
~50

Find a Location

Who is running the clinical trial?

United TherapeuticsLead Sponsor
108 Previous Clinical Trials
14,187 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
2023. "Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05776225.
All > Spokane
~100 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top